SMI Expanded
1.653,17
PKT
-5,04
PKT
-0,30
%
Werbung
Analysen zu SMI Expanded-Werten
Datum | Rating | Analyst | |
---|---|---|---|
03.02.05 | Baloise Buy | Sarasin Research | |
03.02.05 | Zurich Insurance Neutral | JP Morgan | |
03.02.05 | Roche In-Line | Goldman Sachs | |
03.03.05 | Givaudan Neutral | Sarasin Research | |
03.02.05 | Roche Kaufen | LB Baden-Württemberg | |
07.02.05 | UBS Buy | SEB | |
03.02.05 | Swiss Life Sector Outperform | Vontobel | |
03.02.05 | Swiss Life Outperform | HypoVereinsbank | |
04.02.05 | Swiss Life Outperform | HypoVereinsbank | |
02.02.05 | Swatch (I) Buy | Sarasin Research | |
03.02.05 | Novartis Übergewichten | Reuschel & Co | |
02.02.05 | Roche Buy | Sarasin Research | |
02.02.05 | Swiss Life Overweight | JP Morgan | |
02.02.05 | Roche Halten | Helaba Trust | |
03.02.05 | Roche Buy | Sarasin Research | |
01.02.05 | UBS Neutral | Merrill Lynch | |
01.02.05 | Novartis Kaufen | SYZ & CO | |
01.02.05 | Roche Halten | Helaba Trust | |
01.02.05 | UBS Buy | Merrill Lynch | |
01.02.05 | Zurich Insurance Buy | Sarasin Research | |
01.02.05 | UBS Buy | Sarasin Research | |
31.01.05 | Lonza Reduce | Sarasin Research | |
31.01.05 | Novartis Outperform | Credit Suisse First Boston | |
31.01.05 | Roche Buy | Sarasin Research | |
02.02.05 | UBS Outperform | Credit Suisse First Boston | |
01.02.05 | Roche Neutral | Credit Suisse First Boston | |
01.02.05 | Logitech Kauf | SYZ & CO | |
31.01.05 | Nestlé Neutral | Sarasin Research | |
01.02.05 | Schindler Neutral | Helvea | |
28.01.05 | Holcim Verkaufen | Helaba Trust | |
31.01.05 | Novartis Buy | Helvea | |
31.01.05 | Swatch (I) Buy | Sarasin Research | |
27.01.05 | Lonza Buy | Helvea | |
27.01.05 | Holcim Halten | Helaba Trust | |
03.02.05 | Novartis Outperformer | Sparkasse KölnBonn | |
28.01.05 | Swatch (I) Neutral | JP Morgan | |
27.01.05 | Holcim Neutral | Helvea | |
27.01.05 | Adecco SA Accumulate | Helvea | |
26.01.05 | Novartis Market Perform | William Blair | |
26.01.05 | Lonza Reduce | Sarasin Research |